The use of remdesivir outside of clinical trials during the COVID-19 pandemic

With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and investig...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Pharm Policy Pract
Prif Awduron: Halimi, Vesa, Daci, Armond, Ridova, Nevenka, Panovska-Stavridis, Irina, Stevanovic, Milena, Filipce, Venko, Dimovski, Aleksandar, Grozdanova, Aleksandra
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2020
Pynciau:
Commentary
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7503054/
https://ncbi.nlm.nih.gov/pubmed/32968487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-020-00258-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg